Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings
Published on 11/02/2025 at 19:31 | Redaktion boerse-global.de
Prelude Therapeutics Inc shares are demonstrating remarkable upward momentum, driven by two key factors: a substantial increase in analyst price targets and growing anticipation for next week’s quarterly financial results.
Market participants are looking ahead to next week when Prelude Therapeutics is scheduled to release its third-quarter 2025 financial performance. The company is expected to announce results on Wednesday, followed by a conference call on Friday at 11:30 AM Eastern Time.
Financial analysts project a loss of $0.35 per share for the recently completed quarter. Notably, this forecast has improved significantly over the past month, narrowing from an expected loss of $0.41 to the current $0.35 projection—representing a 14.63% positive revision. The company Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
